Understanding Pleural Effusion Classification
Fluid surrounding the lungs normally serves a protective function, allowing smooth movement during breathing. When excess accumulates, the underlying cause determines whether treatment targets the fluid itself or the systemic condition driving its formation.
Light's criteria divides effusions into two categories:
- Transudate: Fluid crossing intact vessel walls, typically from systemic imbalances like heart failure, cirrhosis, or nephrotic syndrome.
- Exudate: Fluid leaking through damaged vessel walls due to local or systemic inflammation, infection, or malignancy.
This distinction is crucial because transudative effusions rarely require drainage and resolve with treatment of the underlying condition, whilst exudative effusions often signal serious pathology requiring urgent investigation.
Light's Criteria Calculation
Three ratios determine classification. An effusion meets exudative criteria if any of the following is true:
Protein Ratio = Pleural Protein ÷ Serum Protein
LDH Ratio = Pleural LDH ÷ Serum LDH
LDH Upper Ratio = Pleural LDH ÷ Upper Normal Limit of LDH
Exudate criteria:
• Protein Ratio > 0.5
• LDH Ratio > 0.6
• LDH Upper Ratio > 2/3 (≈ 0.67)
Pleural Protein— Protein concentration in the pleural fluid sample (g/dL)Serum Protein— Total protein concentration in the blood serum (g/dL)Pleural LDH— Lactate dehydrogenase level in pleural fluid (IU/L)Serum LDH— Lactate dehydrogenase level in blood serum (IU/L)Upper Normal Limit of LDH— Laboratory-specific upper reference range for serum LDH (varies by lab and age)
Clinical Significance and Common Causes
Identifying effusion type streamlines diagnosis. Transudative effusions stem from systemic dysfunction rather than pleural pathology:
- Congestive heart failure (most common overall)
- Hepatic cirrhosis with portal hypertension
- Nephrotic syndrome
- Severe hypoalbuminemia
- Renal failure
Exudative effusions reflect local or widespread inflammation and demand targeted investigation:
- Pneumonia or parapneumonic effusion
- Malignancy (lung, breast, lymphoma, metastases)
- Tuberculosis
- Pulmonary embolism
- Connective tissue disease (lupus, rheumatoid arthritis)
- Pancreatitis or esophageal rupture
Light's criteria correctly separates transudate from exudate in approximately 95% of cases, though borderline results may require additional testing such as cholesterol, glucose, or cell counts.
Practical Considerations When Using Light's Criteria
Several real-world factors affect interpretation and accuracy of this classification system.
- Sample timing and handling — Pleural and serum samples must be drawn concurrently or within hours to ensure accurate ratio calculations. Delayed processing, haemolysis, or contamination can artificially elevate LDH values and skew results toward an exudative classification.
- Lab-specific reference ranges — LDH upper normal limits vary significantly between laboratories and depend on patient age. Always use the reference range from the laboratory that performed the test, not assumed population values, to avoid miscalculation of the LDH upper ratio.
- Borderline and discordant results — Occasionally, only one or two of the three ratios meets exudative criteria. Borderline cases warrant additional pleural fluid analysis (cell count, glucose, pH, cholesterol) and clinical correlation rather than relying on Light's criteria alone.
- Diuretic use and treated transudates — Patients on diuretics may show artificially elevated pleural protein ratios as the fluid becomes more concentrated, creating diagnostic confusion. Clinical context and imaging findings help resolve ambiguity.
Management After Classification
Once classification is complete, management diverges based on the result and clinical presentation. Transudative effusions typically resolve with treatment of the underlying cause—controlling heart failure, optimising renal function, or managing liver disease—and rarely require pleural intervention unless symptomatic.
Exudative effusions demand investigation to identify the cause. Small, asymptomatic collections may be observed, but larger effusions causing breathlessness, hypoxemia, or significant radiographic opacity warrant drainage via thoracentesis or chest tube placement. Recurrent or loculated effusions sometimes require more definitive procedures such as pleurodesis or fibrinolytic therapy.
Clinicians should never treat Light's criteria as a diagnostic endpoint; rather, it serves as a pivotal triage tool to guide the scope and urgency of further evaluation. A transudate result does not exclude serious disease if clinical features suggest otherwise, and an exudate necessitates systematic search for malignancy, infection, or inflammation.